Latest Regulatory News

Orbital Corporation advances its UAV engine production and hybrid propulsion technology while managing a $0.5 million net cash outflow in Q1 2026, supported by a $43 million business pipeline and new international contracts.

Conrad Asia Energy has taken a decisive step from exploration to production with the Final Investment Decision on its Mako Gas Project, booking reserves for the first time and progressing a major farm-down transaction.

Syntara Limited has raised A$10 million through a two-tranche placement and share purchase plan, backing its Phase 2b myelofibrosis trial and multiple clinical readouts following positive FDA feedback.

Starpharma has confirmed FDA alignment for its DEP® HER2 first-in-human phase 1 trial, with preparations underway for a mid-2026 start. The biotech also progressed strategic partnerships, published promising data with Genentech, and reported a $14.1 million cash balance alongside rising Viraleze™ sales.

Green Technology Metals (ASX: GT1) sharpens focus on its Seymour Lithium Project amid a lithium price rebound, key permitting progress, and extended C$100 million financing interest from Export Development Canada.

Neurotech International has opened its first Phase 3 clinical site for NTI164 targeting Autism Spectrum Disorder, reported positive 90-day toxicology results, and launched a new Rett syndrome research collaboration.

Nickel Industries delivered its strongest quarterly earnings since late 2023, propelled by a 222% jump in ore sales and significant margin improvements across its nickel processing operations amid favourable regulatory changes and rising nickel prices.

CZR Resources has unveiled strong assay results from its Croydon Gold Project, confirming a significant gold system open in all directions. The company advances exploration at Edamurta and Yarrie, supported by a robust cash position.

Mayne Pharma’s third quarter results show modest revenue growth but a sharp improvement in cash flow and earnings, powered by the strong launch of DistributeRx and robust Women’s Health sales.

Cleo Diagnostics (ASX:COV) has hit a major milestone by completing sample collection for its pivotal U.S. ovarian cancer trial, while progressing manufacturing and analytical validation steps toward FDA 510(k) submission.

Neometals Ltd has launched a 1-for-6 entitlement offer at A$0.04 per share alongside a two-tranche placement, targeting a combined A$13 million to advance gold and critical minerals projects.

Metal Bank is pushing towards near-term gold production in Western Australia and expanding its critical minerals footprint in Queensland, backed by new processing partnerships and exploration milestones.